Subscribe to RSS
DOI: 10.1055/s-0030-1258080
Synthesis of 2-Substituted Pyrimidines via Cross-Coupling Reaction of Pyrimidin-2-yl Sulfonates with Nucleophiles in Polyethylene Glycol 400
Publication History
Publication Date:
10 June 2010 (online)
Abstract
A mild and rapid procedure to the synthesis of 2-substituted pyrimidines was developed via sequential functionalization of easily available Biginelli 3,4-dihydropyrimidine-2(1H)-ones via oxidation, esterification, followed by cross-coupling reaction of pyrimidin-2-yl sulfonates with N, S, and O nucleophiles in PEG-400 as a green reaction medium at room temperature.
Keywords
2-substituted pyrimidines - oxidation - esterification - cross-coupling reaction - PEG-400
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Heldebrant D.Jessop PG. J. Am. Chem. Soc. 2003, 125: 5600 -
1b
Hesis L.Gais HJ. Tetrahedron Lett. 1995, 36: 3833 -
1c
Haimov A.Neumann R. Chem. Commun. 2002, 876 -
1d
Wang X.-C.Quan Z.-J.Zhang Z. Tetrahedron 2007, 63: 8227 -
2a
Chandrasekhar S.Narsihmulu Ch.Sultana SS.Reddy NR. Org. Lett. 2002, 4: 4399 -
2b
Ackermann L.Vicente R. Org. Lett. 2009, 11: 4922 -
2c
Zhou W.-J.Wang K.-H.Wang J.-X. J. Org. Chem. 2009, 74: 5599 -
3a
Biginelli P. Gazz. Chim. Ital. 1893, 23: 360 -
3b
Kappe CO. Tetrahedron 1993, 49: 6937 -
3c
Kappe CO. Acc. Chem. Res. 2000, 33: 879 -
3d
Kappe CO.Stadler A. Org. React. 2004, 63: 1 -
3e
Dallinger D.Stadler A.Kappe CO. Pure Appl. Chem. 2004, 76: 1017 -
3f
Gong LZ.Chen XH.Xu XY. Chem. Eur. J. 2007, 13: 8920 -
3g
Kolosov MA.Orlov VD. Mol. Diversity 2009, 13: 5 -
3h
Quan Z.-J.Zhang Z.Da Y X.Wang X.-C. Chin. J. Org. Chem. 2009, 29: 876 ; in Chinese -
4a
Kappe CO. Eur. J. Med. Chem. 2000, 35: 1043 -
4b
Deres K.Schroder CH.Paessens A.Goldmann S.Hacker HJ.Weber O.Kraemer T.Niewoehner U.Pleiss U.Stoltefuss J.Graef E.Koletzki D.Masantschek RNA.Reimann A.Jaeger R.Groß R.Beckermann B.Schlemmer K.-H.Haebich D.Rubsamen-Waigmann H. Science 2003, 299: 893 -
4c
Lengar A.Kappe CO. Org. Lett. 2004, 6: 771 -
4d
Sing K.Arora D.Poremsky E.Lowery J.Moreland RS. Eur. J. Med. Chem. 2009, 44: 1997 -
4e
Singh K.Arora D.Singh K.Singh S. Mini Rev. Med. Chem. 2009, 9: 95 -
5a
Snider BB.Shi Z. J. Org. Chem. 1993, 58: 3828 -
5b
Patil AD.Kumar NV.Kokke WC.Bean MF.Freyer AJ.DeBrosse C.Mai S.Truneh A.Gaulkner DJ.Carte B.Breen AL.Hertzberg RP.Johnson RK.Westly JW.Potts BC. J. Org. Chem. 1995, 60: 1182 -
5c
Aron ZD.Overman LE. Chem. Commun. 2004, 253 - 6 The Merck Index, An Encyclopedia of Chemicals, Drugs and Biologicals 13th ed.: Merck; Whitehouse Station: 2001.
-
7a
Kappe CO.Roschger P. J. Heterocycl. Chem. 1989, 26: 55 -
7b
Gholap AR.Toti KS.Shirazi F.Deshpande MV.Srinivasan KV. Tetrahedron 2008, 64: 10214 -
8a
Watanabe M.Koike H.Ishiba T.Okada T.Seo S.Hirai K. Bioorg. Med. Chem. 1997, 5: 437 -
8b
Kim DC.Lee YR.Yang B.-S.Shin KJ.Kim DJ.Chung BY.Yoo KH. Eur. J. Med. Chem. 2003, 38: 525 -
8c
Kasparec J.Adams JL.Sisko J.Silva DJ. Tetrahedron Lett. 2003, 44: 4567 -
8d
Gayo LM.Suto MJ. Tetrahedron Lett. 1997, 38: 211 -
8e
Matloobi M.Kappe CO. J. Comb. Chem. 2007, 9: 275 -
8f
Obrecht D.Abrecht C.Grieder A.Villalgordo JM. Helv. Chim. Acta 1997, 80: 65 -
8g
Vanden Eynde JJ.Labuche N.Van Haverbeke Y.Tietze L. ARKIVOC 2003, (xv): 22 - 9
Vanden Eynde JJ.Audiart N.Canonne V.Michel S.Van Haverbeke Y.Kappe CO. Heterocycles 1997, 45: 1967 - 10
Yamamoto K.Chen YG.Buono FG. Org. Lett. 2005, 7: 4673 - 11
Kang FA.Kodah J.Guan QY.Li XB.Murray WV. J. Org. Chem. 2005, 70: 1957 - 12
Matsushima A,Oda M,Kawachi Y, andChika J. inventors; WO 03/006439 A1. -
13a
Rueter JK.Nortey SO.Baxter EW.Leo GC.Reitz AB. Tetrahedron Lett. 1998, 39: 975 -
13b
Zhang MJ.Moore JD.Flynn DL.Hanson PR. Org. Lett. 2004, 6: 2657 -
13c
Cho C.-L.Yun H.-S.Park K. J. Org. Chem. 2003, 68: 3017 -
13d
Choi JH.Lee BC.Lee HW.Lee I. J. Org. Chem. 2002, 67: 1277 -
13e
Gao C.-Y.Yang L.-M. J. Org. Chem. 2008, 73: 1624 - 14
Bříza T.Král V.Martásek P.Kaplánek R. J. Fluorine Chem. 2008, 129: 235
References and Notes
General Procedure
for the Preparation of
3
To a stirred mixture of compound 2 (1 mmol) and
p-toluenesulfonyl
chloride (1.5 mmol) in PEG-400 (2 g), K2CO3 (1.5
mmol) was added at 0 ˚C. The reaction mixture was taken
slowly to r.t. and stirred for ca. 40 min. After complete conversion
(TLC monitoring), the crude reaction mixture was poured into H2O
to induce precipitation. The solid was filtered and washed with
copious amounts H2O, then recrystallized from EtOH to
give pure pyrimidin-2-yl sulfonates 3 as
white solid.
Selected Data for Compound
3a
Mp 106-108 ˚C. ¹H
NMR (400 MHz, CDCl3): δ = 1.06
(t,
3 H, J = 7.2
Hz), 2.45 (s, 3 H), 2.57 (s, 3 H) 4.20 (q, 2 H, J = 7.2
Hz), 7.32-8.03 (m, 9 H). ¹³C
NMR (100 MHz, CDCl3): δ = 13.6,
21.7, 22.5, 62.2, 123.8, 128.5, 128.5, 129.3, 129.4, 130.8, 133.8,
136.3, 145.5, 158.7, 166.7, 167.2, 169.6. ESI-MS: m/z = 413 [M + H+].
Table 3 Coupling of Pyrimidin-2-yl Sulfonates 3 with Phenol |
|
Entry | Sulfonate 3 | R | Product 7 | Yield (%)c | |||||||||||||||
|
|||||||||||||||||||
1a | 3a | H | 7a | 88 | |||||||||||||||
2b | 3a | H | 7a | 90 | |||||||||||||||
3a | 3a | Cl | 7b | 80 | |||||||||||||||
a Reaction
conditions A: 3 (1.0 mmol), phenol (1.5
mmol), K2CO3 (1.5 mmol), PEG-400 (2.0 g),
r.t., 60 min. b Reaction conditions B: 3 (1.0 mmol), phenol (1.5 mmol), NaOt-Bu (1.5 mmol), PEG-400 (2 g), r.t., 90 min. c Isolated yield. | |||||||||||||||||||
|
General Procedure
for the Preparation of
4 and 5
To a stirred mixture of
compound 3 (1 mmol) in PEG-400 (2 g) at
r.t. were added nucleophiles (1.5 mmol) and K2CO3 (1.5 mmol).
After the mixture was stirred at r.t. for 0.5-1 h (TLC monitoring),
it was poured into H2O to induce precipitation. The solid
was filtered and washed with copious amounts water, then recrystallized
from EtOH and PE to give pure products 4 and 5 as white solid.
Selected
Data for Compounds 4a
Mp 118-119 ˚C. ¹H
NMR (400 MHz, CDCl3): δ = 0.95
(t, 3 H, J = 7.2
Hz), 2.50 (s, 3 H), 3.76 (t, 4, J = 4.8
Hz), 3.93 (m, 3 H), 4.04 (q, 2 H, J = 7.2
Hz), 7.40-7.58 (m, 5 H). ¹³C
NMR (100 MHz, CDCl3): δ = 13.5,
23.1, 44.1, 60.9, 66.9, 114.5, 128.1, 128.2, 129.5, 139.3, 160.2,
165.7, 167.0, 168.9. ESI-MS: m/z 328 ([M+H+]).
Selected Data for Compounds 5a
Mp
65-66 ˚C. ¹H NMR (400 MHz,
CDCl3): δ = 1.04
(t, 3 H, J = 7.2
Hz), 2.39 (s, 3 H), 2.50 (s, 3 H), 4.14 (q, 2 H, J = 7.2 Hz),
7.21-7.53 (m, 9 H). ¹³C NMR
(100 MHz, CDCl3): δ = 13.6,
21.3, 22.6, 61.7, 121.4, 125.9, 128.3, 128.4, 129.7, 130.1, 135.1,
137.4, 139.2, 163.5, 165.8, 168.1, 172.4. ESI-MS: m/z = 365 [M + H+].
General Procedure
for the Preparation of 6
To a stirred mixture of compound 3 (1 mmol) in PEG-400 (2 g) at r.t. were
added nucleophiles (1.5 mmol) and NaOt-Bu (1.5
mmol). After the mixture was stirred at r.t. for 1.5 h (TLC monitoring),
the reaction mixture was treated with H2O, and extracted
with EtOAc, the organiclayers were dried over Na2SO4.
The crude product was purified by flash chromatography (PE-EtOAc, 10:1)
to give pure products 6 as colorless oil.
Selected Data for Compound 6a
¹H
NMR (400 MHz, CDCl3): δ = 0.92
(t, 3 H, J = 7.2
Hz), 1.34 (t, 3 H, J = 6.8
Hz), 2.47 (s, 3 H), 4.05 (m, 2 H), 4.40 (q, 2 H, J = 7.2
Hz), 7.30-7.56 (m, 5 H). ¹³C
NMR (100 MHz, CDCl3): δ = 13.4,
14.2, 22.5, 61.3, 63.5, 119.5, 128.0, 128.1, 129.8, 137.7, 163.9,
166.2, 168.1, 168.4. ESI-MS: m/z = 287 [M + H+].